PMID- 37429607 OWN - NLM STAT- MEDLINE DCOM- 20231129 LR - 20231129 IS - 1742-481X (Electronic) IS - 1742-4801 (Print) IS - 1742-4801 (Linking) VI - 20 IP - 10 DP - 2023 Dec TI - Human umbilical cord mesenchymal stem cell-derived exosomes combined with gelatin methacryloyl hydrogel to promote fractional laser injury wound healing. PG - 4040-4049 LID - 10.1111/iwj.14295 [doi] AB - To investigate whether human umbilical cord mesenchymal stem cell-derived exosomes combined with gelatin methacryloyl (GelMA) hydrogel are beneficial in promoting healing of laser-injured skin wounds in mice. Supernatants of cultured human umbilical cord mesenchymal stem cells (HUC-MSCs) were collected to obtain human umbilical cord MSC-derived exosomes (HUC-MSCs-Exos), which were combined with GelMA hydrogel complex to treat a mouse fractional laser injury model. The study was divided into PBS group, EX (HUC-MSCs-Exos) group, GEL (GelMA hydrogel) group and EX+GEL (HUC-MSCs-Exos combined with GelMA hydrogel) group. The healing of laser-injured skin in each group was observed by gross view and dermatoscopy, and changes in skin structure, angiogenesis and proliferation-related indexes were observed during the healing process of laser-injured skin in each group. The results of the animal experiments showed that the EX and GEL groups alone and the EL+EX group exhibited less inflammatory response compared to the PBS group. The EX and GEL groups showed marked tissue proliferation and favourable angiogenesis, which promoted the wound healing well. The GEL+EX group had the most significant promotion of wound healing compared to the PBS group. qPCR results showed that the expression levels of proliferation-related factors, including KI67 and VEGF and angiogenesis-related factor CD31, were significantly higher in the GEL+EX group than in the other groups, with a time-dependent effect. The combination of HUC-MSCs-Exos and GelMA hydrogel is beneficial in reducing the early inflammatory response of laser-injured skin in mice and promoting its proliferation and angiogenesis, which in turn promotes wound healing. CI - (c) 2023 The Authors. International Wound Journal published by Medicalhelplines.com Inc and John Wiley & Sons Ltd. FAU - Zhang, Xinling AU - Zhang X AD - Department of Plastic Surgery, Peking University Third Hospital, Beijing, China. FAU - Ding, Pengbing AU - Ding P AD - Department of Plastic Surgery, Peking University Third Hospital, Beijing, China. FAU - Chen, Yujie AU - Chen Y AD - Department of Plastic Surgery, Peking University Third Hospital, Beijing, China. FAU - Lin, Zhiyu AU - Lin Z AD - Department of Plastic Surgery, Peking University Third Hospital, Beijing, China. FAU - Zhao, Xun AU - Zhao X AD - Department of Plastic Surgery, Peking University Third Hospital, Beijing, China. FAU - Xie, Hongbin AU - Xie H AUID- ORCID: 0009-0003-3723-1814 AD - Department of Plastic Surgery, Peking University Third Hospital, Beijing, China. LA - eng GR - H65469-05/Beijing Regenerative Biotechnology Research Institute/ PT - Journal Article DEP - 20230710 PL - England TA - Int Wound J JT - International wound journal JID - 101230907 RN - 0 (Hydrogels) RN - 0 (gelatin methacryloyl) SB - IM MH - Humans MH - Mice MH - Animals MH - Hydrogels/therapeutic use MH - *Exosomes/metabolism MH - Wound Healing/physiology MH - Disease Models, Animal MH - Umbilical Cord MH - *Mesenchymal Stem Cells PMC - PMC10681517 OTO - NOTNLM OT - exosomes OT - fractional laser injury wound OT - gelatin methacryloyl hydrogel OT - mesenchymal stem cells OT - umbilical cord COIS- The authors declare no competing interests. EDAT- 2023/07/11 01:08 MHDA- 2023/11/29 06:42 PMCR- 2023/07/10 CRDT- 2023/07/10 20:33 PHST- 2023/06/08 00:00 [revised] PHST- 2023/04/27 00:00 [received] PHST- 2023/06/16 00:00 [accepted] PHST- 2023/11/29 06:42 [medline] PHST- 2023/07/11 01:08 [pubmed] PHST- 2023/07/10 20:33 [entrez] PHST- 2023/07/10 00:00 [pmc-release] AID - IWJ14295 [pii] AID - 10.1111/iwj.14295 [doi] PST - ppublish SO - Int Wound J. 2023 Dec;20(10):4040-4049. doi: 10.1111/iwj.14295. Epub 2023 Jul 10.